- Home
- GNPX vs TWG Comparison
GNPX vs TWG Comparison
Compare GNPX & TWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNPX
- TWG
- Stock Information
- Founded
- GNPX 2009
- TWG 2009
- Country
- GNPX United States
- TWG Hong Kong
- Employees
- GNPX N/A
- TWG N/A
- Industry
- GNPX Biotechnology: Pharmaceutical Preparations
- TWG
- Sector
- GNPX Health Care
- TWG
- Exchange
- GNPX Nasdaq
- TWG NYSE
- Market Cap
- GNPX 6.6M
- TWG 7.4M
- IPO Year
- GNPX 2018
- TWG 2024
- Fundamental
- Price
- GNPX $0.23
- TWG $0.13
- Analyst Decision
- GNPX
- TWG
- Analyst Count
- GNPX 0
- TWG 0
- Target Price
- GNPX N/A
- TWG N/A
- AVG Volume (30 Days)
- GNPX 3.6M
- TWG 10.2M
- Earning Date
- GNPX 08-08-2025
- TWG 02-15-2025
- Dividend Yield
- GNPX N/A
- TWG N/A
- EPS Growth
- GNPX N/A
- TWG N/A
- EPS
- GNPX N/A
- TWG N/A
- Revenue
- GNPX N/A
- TWG $4,747,580.00
- Revenue This Year
- GNPX N/A
- TWG N/A
- Revenue Next Year
- GNPX N/A
- TWG N/A
- P/E Ratio
- GNPX N/A
- TWG N/A
- Revenue Growth
- GNPX N/A
- TWG N/A
- 52 Week Low
- GNPX $0.20
- TWG $0.10
- 52 Week High
- GNPX $3.97
- TWG $13.50
- Technical
- Relative Strength Index (RSI)
- GNPX 40.22
- TWG N/A
- Support Level
- GNPX $0.22
- TWG N/A
- Resistance Level
- GNPX $0.32
- TWG N/A
- Average True Range (ATR)
- GNPX 0.03
- TWG 0.00
- MACD
- GNPX -0.01
- TWG 0.00
- Stochastic Oscillator
- GNPX 22.07
- TWG 0.00
About GNPX Genprex Inc.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.
About TWG TOP WEALTH GROUP HLDG LTD
Top Wealth Group Holding Ltd is as supplier of caviar and offer caviar-based gourmet products. It is specialized in supplying high quality sturgeons caviar. Its mission is to become a world-renowned supplier of the finest selection of caviar and offer caviar-based gourmet products around the globe with an unparalleled gastronomical experience.